Abstract: Particular embodiments receive a plurality of values associated with a document. One or more keywords associated with the document are also received. A first score is generated for each value, of the plurality of values. The generation of the first score excluding sending, over a computer network, a first request to one or more remote computing devices to generate the first score. Based at least in part on the generating of the first score, each value, of the plurality of values is ranked. The ranking of each value excluding sending, over the computer network, a second request to the one or more remote computing devices to rank each value. Based on the ranking, at least one value, of the plurality of values, is selected. The selecting being indicative that the at least one value is a candidate to be a constituent of the one or more keywords. Based on the ranking, an indicator indicating that the at least one value is the candidate to be the constituent of the one or more keywords is presented.

Abstract: Provided are certain methods useful in the treatment of pain comprising administering a compound of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB2 receptor;

Abstract: Provided are certain methods useful in the treatment of pain comprising administering a compound of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB2 receptor;

Abstract: Provided are certain methods useful in the treatment of cancer comprising administering a compound of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB2 receptor;

Abstract: Provided are certain methods useful in the treatment of cancer comprising administering a compound of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB2 receptor;

Abstract: This disclosure includes biometrically secured networked devices with enhanced privacy protection. One system includes a first biometrically secured device having a first sensor, and a second biometrically secured device having a second sensor. The first device is programmed to: (i) obtain a first sample of a first biometric using the first sensor; (ii) generate a secret biometrically derived key using the first sample of the first biometric; (iii) encrypt a set of biometric data using the secret biometrically derived key; and (iv) transmit the set of encrypted biometric data to the second biometrically secured device. The second device is programmed to: (i) obtain a second sample of the first biometric using the second sensor; (ii) generate the secret biometrically derived key using the second sample of the first biometric; and (iii) decrypt the set of biometric data using the secret biometrically derived key.

Abstract: Provided are certain methods useful in the treatment of pain comprising administering a compound of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB2 receptor;

Abstract: Provided are certain methods useful in the treatment of pain comprising administering a compound of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB2 receptor;

Abstract: This disclosure includes biometrically secured networked devices with enhanced privacy protection. One system includes a first biometrically secured device having a first sensor, and a second biometrically secured device having a second sensor. The first device is programmed to: (i) obtain a first sample of a first biometric using the first sensor; (ii) generate a secret biometrically derived key using the first sample of the first biometric; (iii) encrypt a set of biometric data using the secret biometrically derived key; and (iv) transmit the set of encrypted biometric data to the second biometrically secured device. The second device is programmed to: (i) obtain a second sample of the first biometric using the second sensor; (ii) generate the secret biometrically derived key using the second sample of the first biometric; and (iii) decrypt the set of biometric data using the secret biometrically derived key.

Abstract: Provided are certain methods useful in the treatment of pain comprising administering a compound of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB2 receptor;

Abstract: Provided are certain methods useful in the treatment of cancer comprising administering a compound of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB2 receptor;

Abstract: Various methods and devices that involve biometrically secured networked devices with enhanced privacy protection are disclosed. For example, a computer-implemented method for onboarding a first biometrically secured device to a network is disclosed. The method comprises generating an asymmetric key pair, transmitting the public key to a second device, and receiving an encrypted master encryption key from the second device. The master key is encrypted with the public key. The method also comprises decrypting the encrypted master encryption key using the private key and receiving an encrypted set of biometric data. The encrypted set of biometric data is a set of biometric data that is encrypted with the master encryption key. The method also comprises storing the set of biometric data on a memory of the first device. The set of biometric data uniquely identifies at least two users that are registered to use both the first and second devices.

Abstract: Provided are certain methods useful in the treatment of pain comprising administering a compound of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB2 receptor;

Abstract: Various methods and devices that involve biometrically secured networked devices with enhanced privacy protection are disclosed. For example, a computer-implemented method for onboarding a first biometrically secured device to a network is disclosed. The method comprises generating an asymmetric key pair, transmitting the public key to a second device, and receiving an encrypted master encryption key from the second device. The master key is encrypted with the public key. The method also comprises decrypting the encrypted master encryption key using the private key and receiving an encrypted set of biometric data. The encrypted set of biometric data is a set of biometric data that is encrypted with the master encryption key. The method also comprises storing the set of biometric data on a memory of the first device. The set of biometric data uniquely identifies at least two users that are registered to use both the first and second devices.

Abstract: Provided are certain methods useful in the treatment of cancer comprising administering a compound of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB2 receptor;

Abstract: Provided are certain methods useful in the treatment of pain comprising administering a compound of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB2 receptor;

Abstract: Provided are certain methods useful in the treatment of pain comprising administering a compound of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB2 receptor;

Abstract: Provided are certain methods useful in the treatment of cancer comprising administering a compound of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB2 receptor;

Abstract: Provided are certain methods useful in the treatment of pain comprising administering a compound of Formula Ia and pharmaceutical compositions thereof that modulate the activity of the cannabinoid CB2 receptor;

Abstract: The invention provides compositions containing an antigen and a TIM targeting molecule. The invention additionally provides a TIM targeting molecule conjugate, for example, a TIM targeting molecule targeted to a therapeutic or diagnostic moiety. The invention additionally provides methods of using such compositions. In one embodiment, the invention provides a method of stimulating an immune response in an individual by administering a composition comprising an antigen and a TIM targeting molecule in a pharmaceutically acceptable carrier. In another embodiment, the invention provides a method of stimulating an immune response in an individual by administering an antigen and a TIM targeting molecule, which can be administered together in a single composition or separately.